Literature DB >> 6375227

Effect of PHA-B fraction of Agaricus bisporus lectin on insulin release and 45Ca2+ uptake by islets of Langerhans in vitro.

N Ahmad, R Bansal, A K Rastogi, J R Kidwai.   

Abstract

The effect of a purified PHA-B fraction of Agaricus bisporus lectin on insulin release and 45Ca2+ uptake by islets of Langerhans was studied. It was found that at 2 mM glucose +17.5 micrograms/ml A. bisporus PHA-B (which produces half-maximal stimulation) there was a 3.3 fold increase in insulin secretion as compared to controls (2 mM glucose). Stimulation of insulin release was found to be dose-related as well as time-dependent. Maximal stimulation of insulin release was obtained at a lectin concentration of about 60 micrograms/ml and proceeded as a linear function of time for about 1 h. It was found that in the presence of 2 mM glucose +17.5 micrograms/ml lectin islet 45Ca2+ uptake was enhanced more than 11-fold as compared to controls. 45Ca2+ uptake was found to be lectin dose- and time-dependent and maximal uptake was achieved at a lectin concentration of about 60 micrograms/ml after which the rate slowed down until it reached a stationary phase at about 75 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375227     DOI: 10.1007/bf02624765

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  19 in total

1.  The plasminogen activator activity of arteries and veins in diabetes mellitus.

Authors:  L O Almér; M Pandolfi; M Aberg
Journal:  Thromb Res       Date:  1975-02       Impact factor: 3.944

Review 2.  Clinical pharmacology of oral antidiabetic agents (second of two parts).

Authors:  S W Shen; R Bressler
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

3.  Letter: Fibrinolytic activity and treatment of diabetes.

Authors:  N R Farid; J Anderson; A Martin; D Weightman
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

4.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.

Authors:  G L Knatterud; C L Meinert; C R Klimt; R K Osborne; D B Martin
Journal:  JAMA       Date:  1971-08-09       Impact factor: 56.272

5.  The University Group Diabetes Program. A statistician looks at the mortality results.

Authors:  S Schor
Journal:  JAMA       Date:  1971-09-20       Impact factor: 56.272

6.  A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

Authors:  C L Meinert; G L Knatterud; T E Prout; C R Klimt
Journal:  Diabetes       Date:  1970       Impact factor: 9.461

7.  [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].

Authors:  J Pirart
Journal:  Nouv Presse Med       Date:  1972-01-29

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complications.

Authors:  G Grignani; G Gamba; D Geroldi; L Pacchiarini; B Solerte; E Ferrari; E Ascari
Journal:  Thromb Haemost       Date:  1981-10       Impact factor: 5.249

10.  Hypoglycemic therapy and hemostasis in maturity- onset diabetes mellitus: existence of an early prethrombotic state.

Authors:  G Grignani; G Gamba; M Biancardi; R De Marco; M Grassi; E Ferrari
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar
View more
  4 in total

1.  Effect of age on Agaricus bisporus PHA-B stimulated insulin release and 45Ca2+ uptake in vitro by islets of Langerhans.

Authors:  N Ahmad; M M Khan; A K Rastogi; J R Kidwai
Journal:  Acta Diabetol Lat       Date:  1984 Oct-Dec

Review 2.  Lectins from the Edible Mushroom Agaricus bisporus and Their Therapeutic Potentials.

Authors:  Wangsa Tirta Ismaya; Raymond Rubianto Tjandrawinata; Heni Rachmawati
Journal:  Molecules       Date:  2020-05-20       Impact factor: 4.411

Review 3.  Mushrooms as Potential Sources of Active Metabolites and Medicines.

Authors:  Anne Bhambri; Malay Srivastava; Vivek G Mahale; Sushma Mahale; Santosh Kumar Karn
Journal:  Front Microbiol       Date:  2022-04-26       Impact factor: 6.064

Review 4.  Edible Mushrooms: A Comprehensive Review on Bioactive Compounds with Health Benefits and Processing Aspects.

Authors:  Krishan Kumar; Rahul Mehra; Raquel P F Guiné; Maria João Lima; Naveen Kumar; Ravinder Kaushik; Naseer Ahmed; Ajar Nath Yadav; Harish Kumar
Journal:  Foods       Date:  2021-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.